Illumina Fails To Revive 2 DNA Patents On Appeal
European patent officials have revoked two of Illumina Cambridge Ltd.'s patents for DNA-sequencing techniques, ruling that the patented claims went beyond the original application, in the latest setback for the biotech...To view the full article, register now.
Already a subscriber? Click here to view full article